Literature DB >> 7826158

Peritonectomy procedures.

P H Sugarbaker1.   

Abstract

OBJECTIVE: New surgical procedures designed to assist in the treatment of peritoneal surface malignancy were sought.
BACKGROUND: Decisions regarding the treatment of cancer depend on the anatomic location of the malignancy and the biologic aggressiveness of the disease. Some patients may have isolated intra-abdominal seeding of malignancy of limited extent or of low biologic grade. In the past, these clinical situations have been regarded as lethal.
METHODS: The cytoreductive approach may require six peritonectomy procedures to resect or strip cancer from all intra-abdominal surfaces.
RESULTS: These are greater omentectomy-splenectomy; left upper quadrant peritonectomy; right upper quadrant peritonectomy; lesser omentectomy-cholecystectomy with stripping of the omental bursa; pelvic peritonectomy with sleeve resection of the sigmoid colon; and antrectomy.
CONCLUSIONS: Peritonectomy procedures and preparation of the abdomen for early postoperative intraperitoneal chemotherapy were described. The author has used the cytoreductive approach to achieve long-term, disease-free survival in selected patients with peritoneal carcinomatosis, peritoneal sarcomatosis or mesothelioma.

Entities:  

Mesh:

Year:  1995        PMID: 7826158      PMCID: PMC1234492          DOI: 10.1097/00000658-199501000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  14 in total

1.  Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment.

Authors:  P H Sugarbaker; K Kern; E Lack
Journal:  Dis Colon Rectum       Date:  1987-10       Impact factor: 4.585

2.  Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors.

Authors:  K S Hughes; R B Rosenstein; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert
Journal:  Dis Colon Rectum       Date:  1988-01       Impact factor: 4.585

3.  Cytoreductive surgery and intraperitoneal chemotherapy with peritoneal spread of cystadenocarcinoma.

Authors:  P H Sugarbaker
Journal:  Eur J Surg Suppl       Date:  1991-05

4.  Transport of model compounds across the peritoneal membrane in the rat.

Authors:  I J Torres; C L Litterst; A M Guarino
Journal:  Pharmacology       Date:  1978       Impact factor: 2.547

5.  Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture.

Authors:  P H Sugarbaker
Journal:  Can J Surg       Date:  1989-05       Impact factor: 2.089

6.  Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer.

Authors:  G B Feldman; R C Knapp
Journal:  Am J Obstet Gynecol       Date:  1974-08-01       Impact factor: 8.661

7.  Average relative dose intensity and the impact on design of clinical trials.

Authors:  W M Hryniuk
Journal:  Semin Oncol       Date:  1987-03       Impact factor: 4.929

Review 8.  The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.

Authors:  V T De Vita; S M Hubbard; D L Longo
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

Review 9.  Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer.

Authors:  P H Sugarbaker; W J Cunliffe; J Belliveau; E A de Bruijn; T Graves; R E Mullins; P Schlag
Journal:  Semin Oncol       Date:  1989-08       Impact factor: 4.929

10.  Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.

Authors:  J L Speyer; P H Sugarbaker; J M Collins; R L Dedrick; R W Klecker; C E Myers
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

View more
  307 in total

1.  Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies.

Authors:  Pedro Bretcha-Boix; Jose Farré-Alegre; Manuel Sureda; Carlos Dussan; Juan José Pérez Ruixo; Antonio Brugarolas Masllorens
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Colorectal Cancer OncoGuia.

Authors:  Paula Manchon Walsh; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

3.  [Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy].

Authors:  G Glockzin; N Ghali; S A Lang; A Agha; H J Schlitt; P Piso
Journal:  Chirurg       Date:  2007-12       Impact factor: 0.955

Review 4.  Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy.

Authors:  Simon Binder; Andrew L Lewis; J-Matthias Löhr; Michael Keese
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 5.  Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.

Authors:  Terence C Chua; Tristan D Yan; David L Morris
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

6.  Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer.

Authors:  Claudio Zanon; Renzo Clara; Isabella Chiappino; Massimiliano Bortolini; Silvia Cornaglia; Paolo Simone; Francesco Bruno; Leonarda De Riu; Mario Airoldi; Fulvia Pedani
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

7.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experience.

Authors:  Ingmar Königsrainer; Philipp Horvath; Florian Struller; Eva Maria Grischke; Diethelm Wallwiener; Alfred Königsrainer; Stefan Beckert
Journal:  Langenbecks Arch Surg       Date:  2014-05-11       Impact factor: 3.445

8.  Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Review of 936 Cases.

Authors:  Akshat Saxena; Sarah J Valle; Winston Liauw; David L Morris
Journal:  J Gastrointest Surg       Date:  2017-05-30       Impact factor: 3.452

9.  Papillary serous carcinoma of peritoneum: presentation of 2 cases.

Authors:  Jaime Ruiz-Tovar; Joaquí Pérez de Oteyza; Roberto Rojo; Marta Vincenta Collado; Augusto García Villanueva
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

10.  Rare diaphragmatic complications following cytoreductive surgery and HIPEC: report of two cases.

Authors:  Benedikt Lampl; Hubert Leebmann; Max Mayr; Pompiliu Piso
Journal:  Surg Today       Date:  2012-12-07       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.